LATE DIAGNOSIS
Inherited cancer risk is a global working-age blind spot—devastating families, disrupting businesses, and costing healthcare funders and insurers £ billions
Early diagnosis transforms outcomes. Yet > 90% of high risk carriers are unaware and unprotected
Who is KINsight for?
Health Systems
Oncology Centres
Corporate EB Leaders
Private Hospitals
Individuals & Families
Powering Health Ecosystems with AI Insight
A Global Platform for Health Intelligence
ESH AI Healthcare is a subsidiary of ESH Solutions Ltd, Jersey, operating as a dedicated division focused on precision, preventive, and protective healthcare solutions.
Our approach moves healthcare beyond treatment toward early risk detection, personalized health intelligence, and continuous protection, enabling scalable impact across geographies and populations. Designed as a global health intelligence platform, ESH AI Healthcare bridges technology, data, and human outcomes to shape the future of proactive healthcare.
AI Analytics
Predictive models enabling smarter, earlier health decisions
Genetic Intelligence
Personalized risk insights based on genetic profiling
Digital Health Insights
Continuous data translating health signals into action
Patient Advocacy Organisations
We engage with patient advocacy organisations to ensure lived experience continually informs our approach.
Collaboration with national inherited cancer advocacy groups ensures responsible deployment, transparent engagement, and alignment between genomic risk infrastructure and high-risk family needs.





Getting Confirmation
The KINsight platform does not give a medical diagnosis. If you have completed your Genetic Family Tree and been recommended for referral to a genetic service we advise strongly that you take the recommendation and discuss directly with your GP or Primary Care Physician.
The only way to confirm if an individual is a carrier of an inherited genetic risk of cancer is via genetic germline testing and this can be arranged directly with…….
